EULAR 2025 highlights… EULAR 2026 Highlights – Basic and Translational Research 22 Jul 2026 SINGLE-CELL PROFILING OF SKIN AND SYNOVIAL FIBROBLASTS IDENTIFIES OPPOSING IFN-α/β REGULATION IN PsO-ARTHRALGIA AND PsA Abstract format and assignment number: Oral presentation, OP0266 Presenting author: A. Khmelevskaia (Switzerland) Around 30%…
EULAR 2025 highlights… EULAR 2026 Highlights – Spondyloarthritis (non-therapeutic) 22 Jul 2026 Impact of sex on clinical outcomes, treatment exposure, and spinal radiographic progression over a 10-year follow-up in axial spondyloarthritis Abstract format and assignment number: Oral presentation OP0101 Presenting author: D.…
EULAR 2025 highlights… EULAR 2026 Highlights – Spondyloarthritis (therapeutic) 22 Jul 2026 Filgotinib significantly improves disease activity in patients with active axial spondyloarthritis: primary results from the phase 3 OLINGUITO trial Abstract format and assignment number: Oral presentation OP0234 Presenting author: X.…
EULAR 2025 highlights… EULAR 2026 Highlights – Rare & Autoinflammatory Diseases 22 Jul 2026 Diagnostic yield and clinical impact of multigene autoinflammatory panels in adult routine care (2018–2025): the role of pre-test clinical suspicion Abstract format and assignment number: Poster, POS0111 Date: Thursday, 4…
EULAR 2025 highlights… EULAR 2026 Highlights – Other Connective Tissue Disease and Vasculitis 22 Jul 2026 Mosaic loss of the Y chromosome differentiates Giant Cell Arteritis from Polymyalgia Rheumatica across the GCA-PMR spectrum Abstract format and assignment number: Oral presentation, OP0120 Date: Wednesday, 3 June, 17:10-17:20…
EULAR 2025 highlights… EULAR 2026 Highlights – Metabolic & Crystal Arthropathies 22 Jul 2026 Treat-to-target continuation of urate-lowering therapy versus a urate-lowering therapy discontinuation attempt strategy in gout patients in remission (go test finale): a pragmatic open label randomised superiority trial Abstract format and…
EULAR 2025 highlights… EULAR 2026 Highlights – Rheumatoid Arthritis (therapeutic and non-therapeutic) 22 Jul 2026 CD19 CAR T-Cell Therapy in ACPA-Positive, Treatment-Refractory, Active Rheumatoid Arthritis - Data from the Phase 1 of the Prospective, Interventional COMPARE Trial Abstract format and assignment number: Oral presentation OP008 …
Tell Me Something Interesting Tell me something interesting: Activities from the Country Liaison Subcommittee 22 Jul 202622 Jul 2026 The Country Liaison Award From Fer Montero The Country Liaison Award is a new EMEUNET initiative aimed at recognising and highlighting the valuable work carried out by Country Liaisons (CLs)…
Connective Tissue Diseases and Vasculitis… EULAR 2026: Do Not Miss- Vasculitis and other Connective Tissue Diseases 24 May 20261 Jun 2026 Andreu Fernandez-CodinaX Poster 0329 | Friday, 13th June 2025 09:30 CESTClinical Poster Tours: Treatment aspects of small vessels vasculitis and Behcet's diseaseAuthor: M. Shiomi (Japan)Title: Recent glucocorticoid-sparing strategies lead to…
EULAR 2026… EULAR 2026: Do Not Miss – Rare and Autoinflammatory diseases 24 May 20261 Jun 2026 Alessandro TomelleriCountry: Italy Alessandro Tomelleri is a Consultant Rheumatologist and Clinician-Scientist at IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University in Milan, Italy. His research focuses on large vessel…